# DEARER Lens

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dearer-lens

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.dearergroup.com
- Total disclosed funding: $65M
- Latest round: Series C (Jan 22, 2024)
- Investors on record: 6

## About

Established in 2017 and based in Shanghai, China, DEARER Lens operates as a medical equipment company that engages in the design, development, production and sales of colored contacts. It has 5 wholly-owned subsidiaries and 1 holding subsidiary, located in Jilin, Suzhou, Xi'an, and South Korea. There are more than 800 employees in the group. The company has acquired 11 invention patents, 57 utility model patents, 7 appearance patents, and 9 Class III medical device registrations, 8 of which are for colored contact lenses. In 2023, the group obtained the domestic registration certificate for silicone hydrogel daily disposable color film. In January 2024, DEARER Lens closed series C funding.

The company's main business is the design, production, and sales of colored contacts lenses. Its product lines of contact lenses include daily contacts lenses, monthly contacts lenses, semi-annual contacts lenses, annual contacts lenses, etc. Besides, DEARER Lens launched its own brand of colored contacts, REALKOKO. Its clients include Bausch+Lomb, Kilala, Mixmixx, BloomColor, Ella Gril, and other brands.

DEARER Lens will focus on research, development and expansion of colored contact lenses for Class III medical devices.

## Funding rounds

- Series C, Jan 22, 2024 — Legend Capital
- Series B, May 1, 2021, $65M — Legend Capital, CPE Funds Management, Insight Capital
- Series A, Nov 27, 2020 — Insight Capital, FOF Capital, Borchid Capital, Eyebright Medical Technology

## Investors

- Insight Capital — Series A, Series B
- FOF Capital (https://capitalatlas.ai/funds/fof-capital) — Series A
- Borchid Capital (https://capitalatlas.ai/funds/borchid-capital) — Series A
- Eyebright Medical Technology — Series A
- Legend Capital — Series B, Series C
- CPE Funds Management (https://capitalatlas.ai/funds/cpe-funds-management) — Series B